Panel discussion: the evaluation of clot-lysing agents in the treatment of thrombotic disease.
D005341:Fibrinolysin / Q000628:therapy*; D006801:Humans; D013927:Thrombosis / Q000628:therapy*
D005341:Fibrinolysin
FIBRINOLYSIN/therapy; THROMBOSIS/therapy